Background Rising demand for healthcare continues to impact all sectors of the health
service. As a result of the growing ageing population and the burden of chronic disease …

Aim Deprescribing is an increasingly common term in the literature, although no specific
accepted definition exists. We aimed to clarify the concept of deprescribing as used in …

Background Successful deprescribing practices are required to address issues associated
with polypharmacy but are hindered by minimal interprofessional collaboration, time …

Objectives Clinical services have allowed pharmacists to shift from product-oriented to
patient-oriented services. However, the policy and social implications of clinical services in …

Background The SENATOR trial intervention included the provision of computer-generated
medication recommendations to physician prescribers caring for hospitalised older adults …

Objectives Deprescribing is a novel strategy whereby medical professionals aim to optimize
a patient's prescription program by removing redundant medications. Few studies have …

Co‐creation (or co‐design) represents the highest form of stakeholder engagement, but it
can be infeasible to co‐create with all stakeholders through all stages of a research project …

Background In the literature, polypharmacy is commonly defined as using five or more
medicines. Little is known about how physicians and pharmacists define and assess …

Background: There is general agreement among nearly all healthcare stakeholders that
team-based,'Patient-Centered Care'(PCC) is essential to successful prevention and …

Aims Inappropriate polypharmacy poses risks of adverse drug events, high healthcare costs
and mortality. Deprescribing could minimise inappropriate polypharmacy and the …